Lantheus Holdings (LNTH) Capital Expenditures (2014 - 2026)
Lantheus Holdings (LNTH) reported Capital Expenditures of $2.0 million for Q1 2026, down 76.65% year-over-year from $8.7 million in Q1 2025, and up 107.46% quarter-over-quarter from -$27.3 million in Q4 2025.
Lantheus Holdings (LNTH) Capital Expenditures (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Capital Expenditures data on file, last reported at $2.0 million in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $2.0 million, down 76.65% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.7 million (down 112.49% YoY), and the FY2024 annual result was $51.6 million, up 10.89% from the prior year.
- Capital Expenditures improved to $2.0 million in Q1 2026 per LNTH's latest filing, from -$27.3 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $47.0 million in Q3 2024 and troughed at -$29.3 million in Q4 2024.
- A 5-year average of $6.4 million and a median of $2.8 million in 2022 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures surged 1007.99% in 2023, then sank 2520.33% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $2.4 million in 2022, then tumbled by 48.95% to $1.2 million in 2023, then slumped by 2520.33% to -$29.3 million in 2024, then grew by 6.78% to -$27.3 million in 2025, then jumped by 107.46% to $2.0 million in 2026.
- Business Quant data shows LNTH's Capital Expenditures at $2.0 million in Q1 2026, -$27.3 million in Q4 2025, and $27.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 8.83 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 6.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.04 Mn |
| Mar 31, 2026 | 2.04 Mn |
| Dec 31, 2025 | -27.30 Mn |
| Dec 31, 2025 | -27.30 Mn |
| Sep 30, 2025 | 27.30 Mn |
| Sep 30, 2025 | 27.30 Mn |
| Jun 30, 2025 | -8.72 Mn |
| Jun 30, 2025 | -8.72 Mn |
| Mar 31, 2025 | 8.72 Mn |
| Mar 31, 2025 | 8.72 Mn |
| Dec 31, 2024 | -29.29 Mn |
| Dec 31, 2024 | -29.29 Mn |
| Sep 30, 2024 | 47.00 Mn |
| Sep 30, 2024 | 47.00 Mn |
| Jun 30, 2024 | 27.06 Mn |
| Jun 30, 2024 | 27.06 Mn |
| Mar 31, 2024 | 6.85 Mn |
| Mar 31, 2024 | 6.85 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Dec 31, 2023 | 1.21 Mn |